Search Results - "KOBAYASHI, Yoshie"

Refine Results
  1. 1

    Impact of Ph.D. training: a comprehensive analysis based on a Japanese national doctoral survey by Shibayama, Sotaro, Kobayashi, Yoshie

    Published in Scientometrics (2017)
    “…Ph.D. training in academic labs offers the foundation for the production of knowledge workers, indispensable for the modern knowledge-based society…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer by Amioka, Ai, Kadoya, Takayuki, Sueoka, Satoshi, Kobayashi, Yoshie, Sasada, Shinsuke, Emi, Akiko, Masumoto, Norio, Ito, Masaoki, Nakayama, Koh, Okada, Morihito

    Published in Breast cancer (Tokyo, Japan) (01-09-2021)
    “…Background Previously, we reported that Wnt5a-positive breast cancer can be classified as estrogen receptor (ER)-positive breast cancer; its prognosis is worse…”
    Get full text
    Journal Article
  4. 4

    A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis by Fujimoto, Mutsumi, Kobayashi, Yoshie, Kuraoka, Kazuya, Yoshiyama, Tomoyuki, Shigematu, Hideo

    Published in Surgical case reports (01-12-2023)
    “…Background CA15-3 is often elevated in breast cancer recurrence and rarely in ductal carcinoma in situ (DCIS). We report a case of DCIS with elevated CA15-3…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    A Case of Breast Metastasis from Renal Cell Carcinoma by Kawamata, Ayumi, Emi, Akiko, Fujimoto, Mutsumi, Kai, Azusa, Suzuki, Eri, Kobayashi, Yoshie, Sasada, Shinsuke, Masumoto, Norio, Kadoya, Takayuki, Okada, Morihito

    Published in Gan to kagaku ryoho (01-12-2022)
    “…The patient was a woman in her 90s. Right radical nephrectomy for right renal cell carcinoma had been performed 2 years and 6 months ago. Since then, there had…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer by Kobayashi, Yoshie, Lim, Seung-Oe, Yamaguchi, Hirohito

    Published in Seminars in cancer biology (01-10-2020)
    “…Immune checkpoint inhibitors (ICIs) are novel class of anti-cancer drugs that exhibit significant therapeutic effects even in patients with advanced-stage…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Accumulation of cyclitols functioning as compatible solutes in the haptophyte alga Pavlova sp by Kobayashi, Yoshie, Torii, Ayako, Kato, Misako, Adachi, Kyoko

    Published in Phycological research (01-06-2007)
    “…SUMMARY Using nuclear magnetic resonance spectroscopy, we identified and characterized accumulated compatible solutes in cells of the haptophyte alga Pavlova…”
    Get full text
    Journal Article
  12. 12

    Prognostic Value of MRI Assessment of Residual Peritumoral Edema in Breast Cancer Treated With Neoadjuvant Chemotherapy by Shigematsu, Hideo, Fujimoto, Mutsumi, Kobayashi, Yoshie, Yasui, Daisuke, Komoto, Daisuke, Matsuura, Noriaki, Kuraoka, Kazuya, Yoshiyama, Tomoyuki

    Published in Journal of magnetic resonance imaging (29-05-2024)
    “…Peritumoral edema (PE) identified on T2-weighted breast MRI is a factor for poor prognosis in breast cancer. To assess the prognostic value of residual PE…”
    Get full text
    Journal Article
  13. 13

    A Homologue of Pancreatic Trypsin Is Localized in the Acrosome of Mammalian Sperm and Is Released During Acrosome Reaction by Ohmura, Ko, Kohno, Nobuhisa, Kobayashi, Yoshie, Yamagata, Kazuo, Sato, Sayaka, Kashiwabara, Shin-ichi, Baba, Tadashi

    Published in The Journal of biological chemistry (08-10-1999)
    “…We have identified cDNA and genomic clones encoding a homologue of pancreatic trypsin, termed TESP4, as a candidate protein involved in the sperm penetration…”
    Get full text
    Journal Article
  14. 14

    Reconstruction of Geometric and Optical Parameters of Non-Planar Objects with Thin Film by Kobayashi, Yoshie, Morimoto, Tetsuro, Sato, Imari, Mukaigawa, Yasuhiro, Tomono, Takao, Ikeuchi, Katsushi

    “…Here, we propose a novel method to estimate the parameters of non-planar objects with thin film surfaces. Being able to estimate the optical parameters of…”
    Get full text
    Journal Article
  15. 15

    Manufacturing Defects Visualization via Robust Edge-Based Registration by Moteki, Atsunori, Yamaguchi, Nobuyasu, Karasudani, Ayu, Kobayashi, Yoshie, Yoshitake, Toshiyuki, Kato, Junya, Aoyagi, Tomohiro

    “…We propose a visualization method for inspecting manufacturing defects. Industrial products have many straight lines and little texture; therefore, the…”
    Get full text
    Conference Proceeding
  16. 16

    A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast by Kobayashi, Yoshie, Kadoya, Takayuki, Kanno, Emiko, Sasada, Tatsunari, Kajitani, Keiko, Emi, Akiko, Shigematsu, Hideo, Masumoto, Norio, Haruta, Rumi, Kataoka, Tsuyoshi, Arihiro, Koji, Okada, Morihito

    Published in Gan to kagaku ryoho (01-09-2012)
    “…A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast is presented.A 65-year-old woman…”
    Get more information
    Journal Article
  17. 17

    Abstract PS19-23: Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer by Amioka, Ai, Kadoya, Takayuki, Sueoka, Satoshi, Kobayashi, Yoshie, Sasada, Shinsuke, Emi, Akiko, Masumoto, Norio, Ito, Masaoki, Okada, Morihito

    Published in Cancer research (Chicago, Ill.) (15-02-2021)
    “…Purpose: We previously showed that Wnt5a-positive breast cancer belongs to a subgroup of estrogen receptor (ER)-positive breast cancers and its prognosis is…”
    Get full text
    Journal Article
  18. 18

    Abstract P4-09-11: Development of personalized medicine for breast cancer based on elucidation of resistance mechanisms to CDK4/6 inhibitors by Kobayashi, Yoshie, Motoi, Yusuke, Fujimoto, Mutsumi, Shigematsu, Hideo

    Published in Cancer research (Chicago, Ill.) (01-03-2023)
    “…Background CDK4/6 inhibitors are the latest and highly specific CDK inhibitors approved for metastatic and early estrogen receptor (ER)-positive breast cancer…”
    Get full text
    Journal Article
  19. 19
  20. 20